Healthcare Sector Articles Healthcare Sector Articles - Page 2 July 13, 2026 6:35 AM ET3 Overlooked Stocks Positioned for the Next Market RotationBridget BennettNYSE:AFLNASDAQ:LGNNASDAQ:LGNDRead 3 Overlooked Stocks Positioned for the Next Market RotationJuly 8, 2026 7:05 AM ETVertex’s Crinetics Deal Balances Growth with Integration RiskChris MarkochNASDAQ:VRTXNASDAQ:CRNXRead Vertex’s Crinetics Deal Balances Growth with Integration RiskJuly 7, 2026 10:25 AM ETAbivax: Wall Street Catches Up to the DataChris MarkochNASDAQ:ABVXNYSE:ABBVRead Abivax: Wall Street Catches Up to the DataJuly 6, 2026 12:20 PM ETAs Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the WinnerJessica MitacekNYSE:HIMSNYSE:NVONYSE:LLYRead As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the WinnerJune 21, 2026 8:30 AM ET3 Biotech Firms With Major Potential Catalysts in the Coming MonthsNathan ReiffNASDAQ:KRYSNASDAQ:ADMANASDAQ:VERARead 3 Biotech Firms With Major Potential Catalysts in the Coming MonthsJune 20, 2026 6:45 AM ET3 Non-Pharma Firms That Could Benefit From the GLP-1 TrendNathan ReiffNYSE:TDOCNASDAQ:OLLINASDAQ:DXCMRead 3 Non-Pharma Firms That Could Benefit From the GLP-1 TrendJune 20, 2026 6:10 AM ETBeyond the AI Trade: 3 Defensive Stocks Built for StabilityThomas HughesNYSE:UNHNASDAQ:AEPNYSE:BNRead Beyond the AI Trade: 3 Defensive Stocks Built for StabilityJune 18, 2026 7:30 AM ET3 Stocks Doing the Heavy Lifting in Healthcare’s ReboundJessica MitacekNYSE:HUMNYSE:LLYNASDAQ:DXCMRead 3 Stocks Doing the Heavy Lifting in Healthcare’s ReboundJune 15, 2026 7:50 AM ETHealthcare Added 35,200 Jobs—3 Stocks Positioned to BenefitChris MarkochNYSE:UNHNYSE:HCANYSE:EHCRead Healthcare Added 35,200 Jobs—3 Stocks Positioned to BenefitJune 14, 2026 8:00 AM ETWhat to Expect From Q2 Earnings as Tech Strength BroadensThomas HughesNASDAQ:NVDANASDAQ:GOOGLNASDAQ:METARead What to Expect From Q2 Earnings as Tech Strength BroadensJune 11, 2026 10:25 AM ETPatent Cliff Predators: GSK Acquires Nuvalent For $10.6 BillionJeffrey Neal JohnsonNASDAQ:NUVLNYSE:GSKNYSE:PFERead Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 BillionJune 8, 2026 5:40 AM ET3 Longevity ETFs to Buy and Hold (and Hold)Nathan ReiffNYSEARCA:XBINYSEARCA:BMEDNASDAQ:AGNGRead 3 Longevity ETFs to Buy and Hold (and Hold)June 7, 2026 6:45 AM ET3 ETFs For the Coming Genomics RevolutionNathan ReiffBATS:ARKGBATS:HELXNYSEARCA:IDNARead 3 ETFs For the Coming Genomics Revolution Page 2 of 2 ‹ Most Recent12 More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCommunication Services SectorCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingInvestor EducationIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsReal Estate SectorSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorUtilities SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
